Evidence map›Paper›PMID 36628052›Full record

ArticleInternational journal of women's health2023

Management of Wrong Blood Transfusion to an RhD Negative Woman in Labor.

Thomas Larsen Titze, Lars Henrik Dahl Hamnvik, Inga Marie Hauglum, Anne Elisabeth Tonay Carlsen, Lena Tjeldhorn, Nhan Trung Nguyen, Çiğdem Akalın Akkök

Open access · goldAbstract readCase Reports
In one paragraph

Article in International journal of women's health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 6 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Thomas Larsen TitzeDepartment of Laboratory Medicine, Vestre Viken Health Trust, Drammen, Norway.
Lars Henrik Dahl HamnvikDepartment of Hematology, Vestre Viken Health Trust, Drammen, Norway.ORCID 0000-0001-7863-6533
Inga Marie HauglumDepartment of Laboratory Medicine, Vestre Viken Health Trust, Drammen, Norway.
Anne Elisabeth Tonay CarlsenDepartment of Hematology, Vestre Viken Health Trust, Drammen, Norway.
Lena TjeldhornDepartment of Immunology and Transfusion Medicine, Oslo University Hospital, Oslo, Norway.
Nhan Trung NguyenDepartment of Immunology and Transfusion Medicine, Oslo University Hospital, Oslo, Norway.
Çiğdem Akalın AkkökDepartment of Immunology and Transfusion Medicine, Oslo University Hospital, Oslo, Norway.ORCID 0000-0001-7615-2906
Vestre Viken Hospital Trust · NOOslo University Hospital · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Blood transfusion is life-saving in massive hemorrhage. Before pre-transfusion tests with ABO and RhD typing results are available, O RhD negative packed red blood cell (PRBC) units are used without cross-matching in emergency. RhD negative girls and women of child-bearing age should always receive RhD negative blood transfusions to prevent RhD-alloimmunization because anti-D-related hemolytic disease of fetus and newborn (HDFN) can result in mild to severe anemia, and in a worst-case scenario death of an RhD positive fetus and/or newborn. However, "wrong blood to wrong patient" happens unintentionally. Here we report an emergency blood transfusion with one unit of RhD positive PRBCs to an RhD negative young woman when estimated blood loss was 2500 mL during delivery and surgical removal of retained placenta. Realizing the mistake, management with high dose anti-D immunoglobulin (Ig) was initiated to remove the RhD positive red blood cells (RBCs) from the patient's circulation. Such mitigation is recommended only for girls and women of child-bearing age. Follow-up was performed by flow cytometry until RhD positive RBCs were no longer detected. Ten months after the delivery, antibody screening was negative. However, we still do not know whether we managed to prevent RhD-alloimmunization.

Indexed as

alloimmunizationanti-D antibodyanti-D immunoglobulinfetomaternal hemorrhagepregnancyRhesus

Identifiers

PMID36628052
PMCPMC9826603
OpenAlexW4313519990

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.